Alexander Camenzind

Alex Camenzind is a lawyer and patent agent, working in the Intellectual Property Group of Gowling WLG's Ottawa office. He practices primarily in the area of intellectual property litigation, assisting clients with patent, trademark, and copyright matters.

Alex works with a variety of clients to protect, enforce, and defend their intellectual property rights across a range of industries. In addition to infringement and impeachment actions under the Patent Act, he works closely with clients under the Patented Medicines (Notice of Compliance) Regulations. Alex has appeared at the Federal Court and Federal Court of Appeal, as well as assisted on matters in the Ontario courts. He is also a registered patent agent with the Canadian Intellectual Property Office (CIPO); assisting clients with obtaining patent protection for their invention in Canada.

Alex also works with pharmaceutical clients to assist with their regulatory requirements. By providing access to Health Canada's Data Protection provisions; listing patents on the Patent Register to take advantage of the linkage to the PM(NOC) Regulations; and filing patent term extensions through Certificates of Supplementary Protection (CSPs), Alex assists clients in extending and enhancing their IP rights. He also advises clients on their reporting requirements for the Patented Medicines Pricing Review Board (PMPRB). In the event of a negative regulatory decision on these issues, Alex works with clients to protect their interests by way of judicial review through the Federal Court of Canada.

Before joining Gowling WLG, Alex worked as a researcher with the University of Victoria's biochemistry department. His work focused on developing new techniques in the area of proteomics and mass spectrometry. Working with researchers from across North America, Alex analyzed disease biomarkers and developed techniques to improve early disease detection. Alex's work resulted in a number of publications and presentations at conferences.